4.5 Article

CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells

期刊

CELLULAR IMMUNOLOGY
卷 272, 期 2, 页码 230-241

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2011.09.015

关键词

CXCR7; CXCL12; CXCR4; Chemokine receptor; Jurkat T cells

向作者/读者索取更多资源

Chemokine receptors CXCR7 and CXCR4 bind to the same ligand stromal cell derived factor-1alpha (SDF-1 alpha CXCL12). We assessed the downstream signaling pathways mediated by CXCL12-CXCR7 interaction in Jurkat T cells. All experiments were carried out after functionally blocking the CXCR4 receptor. CXCL12, on binding CXCR7, induced phosphorylation of extra cellular regulated protein kinases (ERK 1/2) and Akt. Selective inhibition of each signal demonstrated that phosphorylated ERK 1/2 is essential for chernotaxis and survival of T cells whereas activation of Akt promotes only cell survival. Another interesting finding of this study is that CXCL12-CXCR7 interaction under normal physiological conditions does not activate the p38 pathway. Furthermore, we observed that the CXCL12 signaling via CXCR7 is Gi alpha independent. Our findings suggest that CXCR7 promotes cell survival and does not induce cell death in T cells. The CXCL12 signaling via CXCR7 may be crucial in determining the fate of the activated T cells. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Physiology

MOLECULAR ACTIONS OF GLUCOCORTICOIDS IN CARTILAGE AND BONE DURING HEALTH, DISEASE, AND STEROID THERAPY

Kerstin Hartmann, Mascha Koenen, Sebastian Schauer, Stephanie Wittig-Blaich, Mubashir Ahmad, Ulrike Baschant, Jan P. Tuckermann

PHYSIOLOGICAL REVIEWS (2016)

Article Multidisciplinary Sciences

Cell-based RNAi screening and high-content analysis in primary calvarian osteoblasts applied to identification of osteoblast differentiation regulators

Mubashir Ahmad, Torsten Kroll, Jeanette Jakob, Alexander Rauch, Aspasia Ploubidou, Jan Tuckermann

SCIENTIFIC REPORTS (2018)

Review Immunology

A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology

Mubashir Ahmad, Yasmine Hachemi, Kevin Paxian, Florian Mengele, Mascha Koenen, Jan Tuckermann

FRONTIERS IN IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

RNF40 exerts stage-dependent functions in differentiating osteoblasts and is essential for bone cell crosstalk

Zeynab Najafova, Peng Liu, Florian Wegwitz, Mubashir Ahmad, Liezel Tamon, Robyn Laura Kosinsky, Wanhua Xie, Steven A. Johnsen, Jan Tuckermann

Summary: The role of RNF40-mediated H2B monoubiquitination in bone formation and remodeling is crucial, as shown by the study. Loss of RNF40 affects osteoblast differentiation stage-dependently and results in impaired bone formation but increased bone mass due to disrupted bone cell crosstalk. The mechanism involves modulation of RANKL expression in osteoblasts, impacting osteoclast number and function.

CELL DEATH AND DIFFERENTIATION (2021)

Article Endocrinology & Metabolism

Leukemia inhibitory factor treatment attenuates the detrimental effects of glucocorticoids on bone in mice

Sooyeon Lee, Peng Liu, Mubashir Ahmad, Jan P. Tuckermann

Summary: The study reveals that treatment with LIF can rescue the decreased early osteogenic differentiation and mineralization of osteoblasts induced by GCs, and in vivo LIF treatment protects against GC-mediated trabecular bone loss. This protection is attributed to LIF rescuing the decreased activity of Stat3, MAPK, and Akt signaling pathways caused by GCs, suggesting a potential new therapeutic strategy to prevent GC-induced bone loss.
Article Biochemistry & Molecular Biology

Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice

Benjamin Thilo Krueger, Lena Steppe, Sabine Vettorazzi, Melanie Haffner-Luntzer, Sooyeon Lee, Ann-Kristin Dorn, Anita Ignatius, Jan Tuckermann, Mubashir Ahmad

Summary: Long-term use of glucocorticoids can lead to glucocorticoid-induced osteoporosis, and current drugs for treating bone loss are expensive or have major side effects. Therefore, finding cost-effective small-molecule inhibitors is necessary. This study found that inhibition of Cdk5 improves glucocorticoid-induced bone loss, but does not reverse compromised fracture healing.

BIOMEDICINES (2022)

Article Endocrinology & Metabolism

Downregulation of the Autism Spectrum Disorder Gene Shank2 Decreases Bone Mass in Male Mice

Mubashir Ahmad, Nadine Stirmlinger, Irfana Jan, Ulrich Stifel, Sooyeon Lee, Marcel Weingandt, Ulrike Kelp, Juergen Bockmann, Anita Ignatius, Tobias M. Boeckers, Jan Tuckermann

Summary: Mutations in the postsynaptic scaffold protein Shank2 are associated with autism spectrum disorders (ASD) and an increased risk of fractures in affected patients. This study investigates the direct role of Shank2 in regulating bone mass. The findings indicate that Shank2 is expressed in bone and plays a crucial role in osteoblast differentiation and bone formation. The interaction between Shank2 and proteins known from the central nervous system is identified as important for osteoblast differentiation.

JBMR PLUS (2023)

Article Endocrinology & Metabolism

Wnt1 Boosts Fracture Healing by Enhancing Bone Formation in the Fracture Callus

Melanie Haffner-Luntzer, Deniz Ragipoglu, Mubashir Ahmad, Astrid Schoppa, Lena Steppe, Verena Fischer, Julia Luther, Timur Yorgan, Ernesto Bockamp, Michael Amling, Thorsten Schinke, Anita Ignatius

Summary: Despite improvements in fracture care, a percentage of fractures still heal poorly. The study investigated the potential of Wnt1 as a molecule to improve bone fracture healing. The results showed that Wnt1 promotes bone formation during fracture healing through YAP/BMP signaling. This suggests that Wnt1 could be used as a therapeutic agent for orthopedic complications.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Review Endocrinology & Metabolism

Why Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society

Merle Stein, Florent Elefteriou, Bjorn Busse, Imke A. K. Fiedler, Ronald Young Kwon, Eric Farrell, Mubashir Ahmad, Anita Ignatius, Liam Grover, Liesbet Geris, Jan Tuckermann

Summary: Major achievements in bone research have relied on animal models and in vitro systems. However, the ethical debate surrounding animal experimentation and advancements in in vitro and in silico techniques have challenged their use. This review provides an overview of the strengths and limitations of animal models, as well as in vitro and in silico technologies, in skeletal research. The authors propose that a combination of the right animal model and state-of-the-art technology is essential for advancing bone research.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Cell & Tissue Engineering

Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing

Mubashir Ahmad, Benjamin Thilo Krueger, Torsten Kroll, Sabine Vettorazzi, Ann-Kristin Dorn, Florian Mengele, Sooyeon Lee, Sayantan Nandi, Dilay Yilmaz, Miriam Stolz, Naveen Kumar Tangudu, David Carro Vazquez, Johanna Pachmayr, Ion Cristian Cirstea, Maja Vujic Spasic, Aspasia Ploubidou, Anita Ignatius, Jan Tuckermann

Summary: This study identified Cdk5 as a suppressor of osteoblast differentiation through unbiased kinome RNAi screening. Cdk5 knockdown or inhibition enhanced osteoblastogenesis in vitro, and it was found to regulate osteoblast differentiation through the MAPK pathway. These findings suggest that Cdk5 may be a potential therapeutic target for treating osteoporosis and improving fracture healing.

BONE RESEARCH (2022)

Article Endocrinology & Metabolism

Despite Genetic Iron Overload, Hfe-Hemochromatosis Mice Do Not Show Bone Loss

Alessa Wagner, Betuel Alan, Dilay Yilmaz, Mubashir Ahmad, Peng Liu, Naveen Kumar Tangudu, Jan P. Tuckermann, Maja Vujic Spasic

JBMR PLUS (2019)

Article Cell Biology

Loss of B1 and marginal zone B cells during ovarian cancer

Jeffrey Maslanka, Gretel Torres, Jennifer Londregan, Naomi Goldman, Daniel Silberman, John Somerville, James E. Riggs

Summary: This study investigates the immunobiology of the peritoneum in ovarian cancer, revealing reduced B1 cells in the ascites and selective loss of B1 and marginal zone B cell subsets in the spleen. These findings suggest a correlation between the depletion of B cell subsets and the influx of myeloid-derived suppressor cells during ovarian cancer.

CELLULAR IMMUNOLOGY (2024)